Mixed
Glow Stack (GHK-Cu 50mg, TB-500 10mg, BPC-157 10mg)
GHK-Cu + TB-500 + BPC-157
5.0(1)
From
$119.99
The Anti-Aging category covers pre-mixed multi-peptide formulations and single substrates studied for regenerative and longevity effects. The lead combination is the Glow Stack, a single-vial formulation of GHK-Cu, TB-500, and BPC-157. Alongside it, NAD+ 1000 mg is offered as a central longevity cofactor and substrate for sirtuins, PARP1, and CD38. Together the category covers tissue-specific regeneration as well as mitochondrial and senescence-oriented research programs.
The Glow Stack combines GHK-Cu, TB-500, and BPC-157 in a pre-mixed research formulation and is studied for synergetic effects on collagen synthesis, cell migration, and tissue regeneration.
The Glow Stack is a pre-mixed research formulation containing three peptides in one vial: GHK-Cu, TB-500, and BPC-157. GHK-Cu is a copper tripeptide studied in models of collagen synthesis and skin regeneration. TB-500 is a synthetic fragment of Thymosin beta-4 and is studied in the context of actin polymerization and cell migration. BPC-157 targets FGF-adjacent signaling pathways and is used in tissue-regeneration research. The formulation is designed to study these three peptides in shared research designs on synergetic effects without reconstituting three separate vials.
Anti-Aging groups pre-mixed multi-peptide stacks used in research on regeneration and skin biology. The lead product is the Glow Stack, a research formulation of GHK-Cu, TB-500, and BPC-157 combined in a single vial. GHK-Cu is a copper tripeptide studied in models of collagen synthesis and skin regeneration. TB-500 is a fragment of Thymosin beta-4 and is studied for its effects on actin polymerization and cell migration. BPC-157 addresses FGF-adjacent signaling pathways and is studied in tissue-regeneration models. Combining these three peptides in one vial supports research designs where several pathways are observed in parallel rather than in isolation.
Every peptide component of the Glow Stack is tested individually by High-Performance Liquid Chromatography (HPLC) for purity of at least 99 percent and confirmed in its molecular identity by mass spectrometry. The product page lists amino-acid sequences, molecular weights and, where published data exists, receptor-binding profiles for each component. Certificates of analysis are available on request per component, so researchers can document identity and purity independently before combining them in an assay or preclinical model. The entire category is labeled Research Use Only (RUO) and is not intended for human or veterinary use. Study design, ethical review, and regulatory approvals remain the responsibility of the research institution.
The lyophilized Glow Stack is stable at minus 20 degrees Celsius for up to 24 months and should be kept dry and protected from light until use. For reconstitution, bacteriostatic water is typically added slowly along the wall of the vial, which is then rotated gently rather than shaken. This approach minimizes foam formation and degradation of the individual peptide components caused by shear forces. The reconstituted solution is usable at 2 to 8 degrees Celsius for up to 28 days. Aliquoting into smaller portions reduces repeated freeze-thaw cycles. Detailed protocols on target concentrations, volumes, and typical research designs are provided in the Glow Stack guide.
NAD+ (Nicotinamide Adenine Dinucleotide) complements the Anti-Aging category with a central metabolic cofactor. As a substrate for sirtuins (SIRT1 through SIRT7), PARP1, and CD38, NAD+ addresses pathways not covered by the stack peptides: mitochondrial biogenesis, oxidative phosphorylation, and DNA repair during aging processes. The age-dependent decline of intracellular NAD+ pools in mammalian tissues is well documented and motivates restoration studies. The product is supplied as 1000 mg of lyophilized powder (≥99% HPLC) and is suitable for in-vitro assays measuring sirtuin activity, PARP1 flux, and NAD+/NADH ratios in cell-culture models. Unlike NAD precursors such as NMN or nicotinamide riboside, NAD+ is supplied in its immediately active form and requires no cellular salvage conversion.